Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By stimulating these receptors, https://miriamhpxz134202.blogripley.com/37032872/tirzepatide-a-promising-new-treatment-for-obesity